Friday, November 15, 2024
HomeTagsQIAGEN's blood-based

QIAGEN's blood-based

Neuron23 and QIAGEN Announce Collaboration to Develop the Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN ( NYSE: QGEN;...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics